TD Cowen analyst Tara Bancroft reiterated a Hold rating on Rocket Pharmaceuticals (NASDAQ: RCKT).The analyst comments "Safety was the key ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE